TA total of 239 new drugs that contain ‘sitagliptin,’ the active ingredient of the DPP-4 inhibitor class drug Januvia (MSD), will pour out onto the market on the 2nd of next month.

In terms of the number of companies, 59 companies will be releasing their single-agent generics and 63 will be releasing their fixed-combination generics.

According to industry sources on the 22nd, a total of 239 items (157 single-agent drugs, 82 fixed-combination drugs) will be listed for reimbursement on September 2, the day after the expiration of sitagliptin’s substance patent.

In the case of the single-agent drug, 157 items from 59 companies will be reimbursed. The highest insura